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Surface Enhanced Raman Spectroscopy (SERS) has already been successfully applied to 
detect protease activity in a microscope-based experiment. Here, we aimed to translate 
SERS-based protease activity monitoring to a cheaper, smaller and easier to use 
M>aveguide-based on-chip platform. Using nanoplasmonic slot waveguides we have for 
the first time detected SERS signal of a peptide substrate on a waveguide-based platform 
and are currently working on demonstrating SERS-based on-chip detection of protease 
activity.
Introduction
Surface-Enhanced Raman Spectroscopy (SERS) enables selective and sensitive detection 
of a molecule by acquiring a molecule-specific Raman signal that is enhanced in the 
proximity of a plasmonic nanostructure. Its specificity and the fact that no labelling is 
needed, implies that SERS can be efficiently used to detect the activity, of proteases. 
Proteases are enzymes that catalyse the hydrolysis of peptide bonds and which, amongst 
others, play important roles in various human diseases [1]. They are therefore important 
drug targets and a real-time, multiplexed method to analyze protease activity is desired 
for the development of new drugs that inhibit proteases.
Our group previously showed SERS-based detection of protease activity on a model 
protease (trypsin) in a microscope-based free space measurement using gold nanodomes 
shown in Figure 1 [2], Nanodomes are fabricated via nanosphere lithography, a method 
that provides a large quantity of chips while minimizing cost and effort. It additionally 
avoids e-beam lithography, but still offers good control of the gap size and, consequently, 
the SERS enhancement compared to colloidal approaches.
Figure 1: Gold nanodomes with an average gap size of about 12 nm. a 52° tilted view, 
b Top-down view, c Cross-section of a nanodome gap.
As shown in Figure 2, we label the nanodomes with a substrate for trypsin, i.e. a peptide 
also containing two aromatic amino acids that provide two non-overlapping SERS peaks.
After trypsin cleaves this peptide, we observe a decrease of the SERS peak corresponding 
to the cleaved-off part of the peptide. Thus, the SERS peak intensity ratio provides a 
metric for protease activity.
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Figure 2: SERS-based detection of trypsin activity.
Towards multiplexing with non-natural aromatic amino acids
Our approach also allows multiplexing measurements in which we monitor the activity 
of two (or more) different proteases by using protease-specific peptide substrates with 
non-overlapping SERS peaks (Figure 3). Since there are only three natural aromatic 
amino acids providing SERS signals (phenylalanine, tryptophan and tyrosine), we needed 
to turn to non-natural aromatics to allow for multiplexing.
Figure 3: Multiplexing experiment where we detect the activity of two proteases.
As a first step towards multiplexed measurements, we have successfully incorporated the 
non-natural aromatic amino acid cyano-phenylalanine (CN-F) into a peptide substrate for 
trypsin (Figure 4). The peptide starts with a cysteine residue (C) that anchors the peptide 
to the surface of the gold nanostructure via a gold-sulphur bond [3]. The sequence 
CALNN is required to create a peptide monolayer on the gold surface [4], followed by 
two aromatic cyano-phenylalanines (CN-F) separated by a serine (S). Two cyano- 
phenylalanines provide increased SERS signals however, as these are hydrophobic, we 
separated them with a hydrophilic serine to ensure peptide solubility in aqueous buffers. 
Next, a series of glycines (GGGG) ensures accessibility of the cleavage site for the 
protease. The sequence VR serves as the specific cleavage site for trypsin [5], after which 
the two phenylalanines separated by serine (FSF) provide the second SERS peak. Flence,
the ratio of the peak intensities of F/CN-F is a metric for tryptic cleavage and subsequent 
diffusion of the -GNFSF fraction.
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Figure 4: Peptide substrate for trypsin, with single-letter amino acid code. White letters 
represent aromatic amino acids that provide SERS signals, namely phenylalanine (F) and 
the non-natural cyano-phenylalanine (CN-F).
Using nanodomes we demonstrated that trypsin efficiently cleaved this peptide, resulting 
in an approximate 30% decrease in the intensity of the SERS peak of phenylalanine (F) 
at 1003 cm'1 as shown in Figure 5a. In our experiments, we used nanodomes with gap 
sizes of about 12 nm, which are small enough to provide high SERS enhancement factor, 
but still accessible to trypsin that has an effective radius of 2-3 nm. Flowever, small gap 
sizes limit the accessibility of the peptide substrate, which means that trypsin is not able 
to cleave all the peptide substrates in these gaps and we were therefore not able to observe 
complete disappearance of the F peak. In Figure 5b we show that the decrease in the F 
peak is indeed caused by trypsin cleavage of the peptide substrate, as no change in the 
SERS spectra is detected in the presence of inactivated trypsin or when no trypsin is 
added.
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approximately 30% decrease in the intensity of the SERS peak of phenylalanine (F) at 
1003 cm"1, b The F/CN-F peak intensity ratio only decreases after trypsin addition.
Nanophotonic slot waveguides for on-chip detection of protease activity
To avoid the use of bulky and expensive Raman microscopes, we intend to translate our 
SERS-based protease activity measurements to a cheaper, smaller and easier to use 
waveguide-based on-chip platform. Nanoplasmonic slot waveguides (Figure 6a) provide 
high SERS enhancements while avoiding electron beam lithography, making the 
fabrication of these structures compatible with large-scale production [6]. To fabricate 
nanophotonic slot waveguides, silicon nitride (SisN4) waveguides are first fabricated 
using deep UV lithography, followed by a deposition of a uniform layer of aluminum 
oxide (AI2O3) using atomic layer deposition. Finally, a gold layer (Au) is deposited to 
create a plasmonic gap of approximately 15 nm.
Using doubled aromatic amino acids in the peptide substrate, we increased its SERS 
signal. Combining such an improved peptide substrate with nanoplasmonic slot 
waveguides with high SERS enhancements allowed us to detect SERS signals of a peptide 
substrate on a waveguide-based platform for the first time (Figure 6b). We are currently 
working on improving the stability of the nanophotonic slot waveguide SERS signal, 
which should allow us the first demonstration of SERS-based on-chip detection of 
protease activity.
Figure 6: a Nanoplasmonic slot waveguides provide high SERS enhancement while 
avoiding the use of electron beam lithography [6], b SERS signal of a peptide on a 
waveguide-based platform, detected for the first time.
Conclusions
Following proof-of-concept detection of protease activity on a gold nanodome platform 
[2], we intend to expand our platform to multiplexed measurements. To achieve this, we 
used a combination of natural and non-natural aromatic acids that provide non­
overlapping SERS peaks. We showed that our model protease trypsin efficiently cleaved 
a peptide substrate harboring the non-natural aromatic cyano-phenylalanine. In parallel, 
we have used the same peptide substrate to demonstrate for the first time the detection of 
SERS signals of a peptide on a waveguide-based platform using nanoplasmonic slot 
waveguides. We are currently working towards the proof-of-concept demonstration of 
SERS-based on-chip detection of protease activity.
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